These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7811048)
1. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs. Niwano Y; Seo A; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Antimicrob Agents Chemother; 1994 Sep; 38(9):2204-6. PubMed ID: 7811048 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of hamycin, a polyene antimycotic agent, for experimental cutaneous candidiasis in guinea pigs. Dhuley JN Rocz Akad Med Bialymst; 2000; 45():19-25. PubMed ID: 11712431 [TBL] [Abstract][Full Text] [Related]
3. Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent. Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Antimicrob Agents Chemother; 1995 Oct; 39(10):2353-5. PubMed ID: 8619597 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutic efficacies of neticonazole (SS717) cream and solution in experimental cutaneous Candida albicans infection of guinea pigs]. Maebashi K; Itoyama T; Uchida K; Yamaguchi H; Asaoka T; Iwasa A Jpn J Antibiot; 1993 Oct; 46(10):896-903. PubMed ID: 8254891 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea corporis, a comparative study with ointment and cream preparations]. Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Jpn J Antibiot; 1995 Jan; 48(1):150-4. PubMed ID: 7699840 [TBL] [Abstract][Full Text] [Related]
6. A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs. Maebashi K; Itoyama T; Uchida K; Suegara N; Yamaguchi H J Med Vet Mycol; 1994; 32(5):349-59. PubMed ID: 7844701 [TBL] [Abstract][Full Text] [Related]
7. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum. Niwano Y; Matsui M; Tabuchi T; Kanai K; Hamaguchi H; Miyazaki T; Uchida K; Yamaguchi H Arzneimittelforschung; 1997 Sep; 47(9):1056-60. PubMed ID: 9342423 [TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs. Tatsumi Y; Yokoo M; Arika T; Yamaguchi H Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations]. Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Jpn J Antibiot; 1994 Sep; 47(9):1192-5. PubMed ID: 7990259 [TBL] [Abstract][Full Text] [Related]
10. Wound healing effect of the new imidazole antimycotic lanoconazole in rats. Niwano Y; Koga H; Kanai K; Hamaguchi H; Yamaguchi H Arzneimittelforschung; 1996 Feb; 46(2):218-23. PubMed ID: 8720319 [TBL] [Abstract][Full Text] [Related]
11. In vivo activity of bifonazole in guinea pigs: its characteristic features and comparison with clotrimazole. Yamaguchi H; Uchida K Dermatologica; 1984; 169 Suppl 1():33-45. PubMed ID: 6526090 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the in vitro antifungal activity of lanoconazole, a new topical antimycotic, against Trichophyton spp]. Niwano Y; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Jpn J Antibiot; 1995 Jan; 48(1):146-9. PubMed ID: 7699838 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Niwano Y; Kuzuhara N; Kodama H; Yoshida M; Miyazaki T; Yamaguchi H Antimicrob Agents Chemother; 1998 Apr; 42(4):967-70. PubMed ID: 9559824 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs. Oka H; Niwano Y; Ohmi T; Tanaka T; Uchida M; Yamaguchi H Arzneimittelforschung; 1992 Mar; 42(3):345-9. PubMed ID: 1497697 [TBL] [Abstract][Full Text] [Related]
15. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group. Alomar A; Videla S; Delgadillo J; Gich I; Izquierdo I; Forn J Dermatology; 1995; 190(4):295-300. PubMed ID: 7655109 [TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of the new agent latoconazole in two tinea models. Ohmi T; Konaka S; Uchida M; Yamaguchi H Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809 [TBL] [Abstract][Full Text] [Related]
17. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect. Tatsumi Y; Yokoo M; Arika T; Yamaguchi H Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929 [TBL] [Abstract][Full Text] [Related]
18. Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic. Thienpont D; Van Cutsem J; Van Nueten JM; Niemegeers CJ; Marsboom R Arzneimittelforschung; 1975 Feb; 25(2):224-30. PubMed ID: 1173036 [TBL] [Abstract][Full Text] [Related]
19. Bifonazole--a synopsis of clinical trials worldwide. Status and outlook. Stettendorf S Dermatologica; 1984; 169 Suppl 1():69-76. PubMed ID: 6241160 [TBL] [Abstract][Full Text] [Related]